NFE2L2 and cardiovascular disorder: Modulation of Nrf2/Keap1/HO-1 signaling treats cardiovascular diseases by alleviating oxidative stress in cardiomyocytes, enhancing the cellular antioxidant defense system, and upregulating the viability of cardiomyocytes.